This study shows that cabergoline (single oral-dose) is an acceptable, safe and effective drug for suppressing puerperal lactation. It could be of operational benefit not only for artificial feeding, but also for weaning in those that breast-feed within preventive mother-to-child HIV transmission programmes in resource-limited settings.
Get full access to this article
View all access options for this article.
References
1.
WHO.HIV and Infant Feeding. Guidelines for Decision Makers.Geneva, Switzerland: World Health Organization, 2003
2.
MOH.National Guidelines for Prevention of Mother to Child Transmission of HIV.Lilongwe, Malawi: Ministry of Health and Population, 2003
3.
European Multicentre study group for Cabergoline in lactation inhibition.Single dose cabergoline versus bromocriptine in inhibition of puerperal lactation: randomized, double blind, multicentre study.BMJ1991; 302: 1367–71.
